- Home
- ALGS vs JHI Comparison
ALGS vs JHI Comparison
Compare ALGS & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- JHI
- Stock Information
- Founded
- ALGS 2018
- JHI 1971
- Country
- ALGS United States
- JHI United States
- Employees
- ALGS N/A
- JHI N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- JHI Trusts Except Educational Religious and Charitable
- Sector
- ALGS Health Care
- JHI Finance
- Exchange
- ALGS Nasdaq
- JHI Nasdaq
- Market Cap
- ALGS 53.0M
- JHI 125.7M
- IPO Year
- ALGS 2020
- JHI N/A
- Fundamental
- Price
- ALGS $9.12
- JHI $14.41
- Analyst Decision
- ALGS Strong Buy
- JHI
- Analyst Count
- ALGS 2
- JHI 0
- Target Price
- ALGS $60.00
- JHI N/A
- AVG Volume (30 Days)
- ALGS 73.3K
- JHI 29.5K
- Earning Date
- ALGS 11-05-2025
- JHI 01-01-0001
- Dividend Yield
- ALGS N/A
- JHI 6.80%
- EPS Growth
- ALGS N/A
- JHI N/A
- EPS
- ALGS N/A
- JHI 1.05
- Revenue
- ALGS $3,174,000.00
- JHI N/A
- Revenue This Year
- ALGS N/A
- JHI N/A
- Revenue Next Year
- ALGS $28.79
- JHI N/A
- P/E Ratio
- ALGS N/A
- JHI $12.47
- Revenue Growth
- ALGS N/A
- JHI N/A
- 52 Week Low
- ALGS $3.76
- JHI $11.63
- 52 Week High
- ALGS $46.80
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- ALGS 42.11
- JHI 62.24
- Support Level
- ALGS $10.66
- JHI $14.14
- Resistance Level
- ALGS $11.65
- JHI $14.51
- Average True Range (ATR)
- ALGS 0.80
- JHI 0.11
- MACD
- ALGS -0.25
- JHI 0.01
- Stochastic Oscillator
- ALGS 4.44
- JHI 76.19
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.